Business Context and Reporting Period
This Form 6-K is filed by Galapagos NV (not Lakefront Biotherapeutics NV as indicated in metadata) for the month of June 2019. The filing serves to incorporate by reference a press release dated June 20, 2019, which is attached as Exhibit 99.1. The registrant is a foreign private issuer incorporated in Belgium.
Financial Metrics
The provided filing text does not contain specific financial data. It does not report revenue, profit, cash flow, margins, debt, or liquidity figures. The document is a procedural filing to distribute a press release rather than a financial statement.
Material Changes
The filing text does not disclose specific material changes in financial performance or operations. It references a press release for details on material events but does not summarize the content of that release within the Form 6-K body text provided.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, guidance, outlook, or specific risk factors. It notes that the information in the attached press release is incorporated by reference into the Company's Registration Statements on Forms F-3 and S-8.
Key Facts for Investor Verification
- Verify the content of the attached Exhibit 99.1 (Press Release dated June 20, 2019) for the actual material event or announcement.
- Confirm the registrant name is Galapagos NV, as the metadata reference to "Lakefront Biotherapeutics NV" appears inconsistent with the filing text.
- Note that this filing incorporates information into active Registration Statements (File Nos. 333-230639 and various S-8 filings).